History: First presented in 1962 aged 64. He was dwarfed, with relative shortening of the lower limbs; height 53-5 in (1 -36 m), span 54 in (1 37 m), lower measurement 23-5 in (60 cm). The bridge of the nose was depressed, facial features coarsened and skin and hair were dry. He had no palpable thyroid tissue. There was no family history of dwarfism or thyroid disease. He had attended primary school for only three months but subsequently had worked for forty years as a winder in a ropeworks. He was able to give a full and accurate account of himself. He had never received thyroid medication. He had been investigated elsewhere for a suspected duodenal ulcer two years previously and had also had a herniorrhaphy performed without anasthetic difficulty. At that time radiographic examination of the abdomen had incidently revealed unusual flattening of the femoral heads.
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On admission he complained only of increasing cough and exertional dyspnoea. (1962) : Serum protein-bound iodine 2-0 Pg/100 ml, serum cholesterol 248 mg/ 100 ml. 181J neck uptake: 4 hours 8-1 %, 24 hours 10-5 %. ECG showed T wave changes consistent with myocardial ischaemia but normal voltage. X-rays: chest showed dilatation of ascending aorta; femoral heads showed typical changes of chronic hypothyroidism; skull showed enlargement of pituitary fossa, maximum measurements 20 x 12 mm. Mean 24-hour urinary excretion of 17-oxosteroids was 2-8 mg, 17-OH-corticoids 2-9 mg. During four days' stimulation with 40 units ACTH gel I.M. these levels rose to a maximum of 17-5 and 17-2 mg/24 h respectively; after 3 g metyrapone orally throughout 24 hours the urinary steroids rose to 3-1 and 4-5 mg/24 h respectively. He excreted 76% of a 1,150 ml water load in four hours. Mean urinary gonadotrophin excretion was the equivalent of 3-25 mg/ 24 h on mouse bio-assay. Treatment: He was treated by cautious replacement with small doses of cortisone acetate and L-thyroxine. During the subsequent four years heart failure became increasingly severe with enlargement of the ascending aorta. He ultimately died suddenly at the age of 68 years.
Investigations
At autopsy a large dissecting aneurysm was found in the ascending aorta. This had ruptured into the pericardial cavity causing cardiac tamponade. Only a few thyroid acini were found in the paratracheal fibrous tissue, some acini being cystic. The parathyroids also contained cysts. A 2 x 1 x 1 cm nodule of thyroid composed of re-epithelializing colloid-nodules was found at the base of the tongue. The dilated pituitary fossa contained an atheromatous aneurysm of the internal carotid artery compressing the pituitary anterolaterally (Fig 1) . No pituitary adenoma or cyst was found and the compressed pituitary tissue was not atrophic. The adrenals were not atrophic and spermatogenesis was evident in testicular tubules.
Comment
There was no evidence of hypopituitarism at autopsy. Pituitary fossa enlargement in hypothyroidism was first reported by Niepce (1851) and confirmed by Middlemass (1959) . It is generally assumed that this is due to an increase in TSH production leading to pituitary hyperplasia and possible adenoma formation. In this case the enlargement of the fossa was due to the unusual cause of an aneurysm of the internal carotid artery. Myxcedema has been observed in 18 % of patients with lingual thyroid (Montgomery 1936). The finding of a few thyroid acini and cysts in paratracheal fibrous tissue is of interest in lingual thyroid cases, as they may be related to the development of parafollicular cells (E D Williams, personal communication).
Panhypopituitarism, Testicular Atrophy, Alactasia, Corticosteroid-induced Osteoporosis and Systemic Lupus Erythematosus Induced by Methoin M Cochran MB and B E C Nordin MD FRCP (MRC Mineral Metabolism Research Unit, General Infirmary, Leeds) R W, man aged 37 History: This man was fit and well until 1952 when his skull was fractured in a road accident. He developed lassitude, weight loss and impotence over the next year and in 1958 a diagnosis of pituitary failure was made on clinical grounds, the findings of low urine ketosteroids and ketogenic steroids, and a subnormal BMR. He was discharged on cortisone 25 mg per day and methyl testosterone 20 mg by mouth with good clinical response. His impotence disappeared. In 1963 he again fractured his skull; the cortisone was raised to 75 mg per day by mouth and this dose was not reduced. In 1964 he developed grand mal epilepsy which was controlled by phenytoin 300 mg per day. In 1966 his impotence returned and he lost height and developed a stoop. In addition he became ataxic and methoin 300 mg per day was substituted as the anticonvulsant. In January 1967 he was admitted to hospital with severe spinal osteoporosis. On examination he had a cushingoid face and little body hair.
Investigations: Hb 14-2 g/100 ml. WBC 10,800; film normal. ESR 7 mm in 1 hour (Westergren). Urea 12 mg/100 ml. Sodium 144, potassium 3 4, chloride 100, CO2 combining power 33 mEq/1. Proteins and strip normal. Liver function tests normal. Urine: 17-hydroxycorticosteroids 5.5, 17-ketosteroids less than 0 5 mg/24 h. Testicular biopsy: Tubular atrophy with hyalinization of the basement membranes.
Gastrointestinal and renal investigations: Xylose absorption test (5 g given): 0 59 g at 2 hours, 1-18 g at 5 hours. Glucose tolerance test normal. Lactose absorption test: no rise in blood sugar. Fxecal fats on normal diet 33 g in 5 days; on lactose-free diet 12 g in 5 days.
Creatinine clearance 56 ml/min. Concentrating power with vasopressin 275 mOsm/kg. Lowest urine pH after standard acid load 6-0. Amino-acid pattern normal. Urine WBC 35,000/h. Calcium and bone investigations: X-rays showed marked spinal osteoporosis with crush fractures of TI-5, TIO and Li. X-rays of peripheral bones with densitometry showed no peripheral osteoporosis. Serum calcium 9 4, phosphorus 4-8, creatinine 1-0 mg/100 ml, urine calcium 113 mg/ 24 h; alkaline phosphatase 17 K-A units (97% heat labile, indicating bony source). Iliac crest biopsy showed severe osteoporosis.
Progress: The cortisone was reduced to 20 mg per day. The syndrome of systemic lupus erythematosus appeared with a rash on the forearm, pyrexia, severe limb girdle weakness, pleurisy, aseptic arthritis and a hamolytic ancemia. The ESR was raised (40-107 mm in 1 hour) and LE cells were found on two occasions. A muscle biopsy showed a non-specific myopathy and strum aldolase and creatine kinase were slightly elevated. The appearance of SLE after hydrallazine, hydantoin or procainamide is now well established in the literature and methoin accordingly was replaced by phenobarbitone. There was a total clinical remission of the SLE syndrome with disappearance of the LE cells from the blood although the ESR fell to normal only after some months. The osteoporosis was probably due to the steroids and conceivably aggravated by the alactasia and marginal steatorrhcea. The cause of the renal tubular defects is not understood, but these did not appear to be responsible for the bone disease.
With vitamin D the radio calcium absorption test rose to 45 % (high value) and the alkaline phosphatase returned to normal levels. The patient returned to his work on cortisone 30 mg per day, thyroxin 0 3 g per day. An implant of 3 g of testosterone had no effect on his impotence.
